rss
Gut 2009;58:1679 doi:10.1136/gut.2009.199307
  • JournalScan

JournalScan

  1. Guru Aithal, Editor

    Colorectal cancer and a potential treatment role for aspirin

    ‣ Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 2009;302:649–58.

    Long-term high dose aspirin in randomised trials suggests it may also reduce the risk of colorectal neoplasia. To assess the influence of aspirin on survival after the diagnosis of colorectal cancer, Chan et al carried out a prospective cohort study of 1279 subjects diagnosed with stage I, II or III colorectal cancer. These participants were in the Nurses Health Study and the Health Professionals Follow-up Study in the USA, enrolled in the 1980s (prior to diagnosis) and followed up to June 2008. After a median of 12 years, compared with non-users, participants who regularly used aspirin after diagnosis experienced a hazard ratio (HR) for colorectal cancer-specific mortality of 0.71 (95% CI 0.53 to 0.95) and for overall mortality of 0.79 (95% CI 0.65 to 0.97). Among 719 who did not use aspirin before diagnosis, aspirin use after diagnosis …

    [Full text of this article]

    This Article

    1. Extract
    2. Full text
    3. PDF

    Google Scholar

    1. Articles by Aithal, G.

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.